#BiotechInsights

Exciting updates from Sartorius and Adimmune Corp (4142)'s corporate seminar! Sartorius experts, Tse-Wei Chen and RZ Lin, highlighted the latest trends in cell culture development and the key specifications of the new PIC/S #GMP Annex 1 regulation.

Adimmune's newly established cell culture facility with TFDA GMP certification signifies a significant milestone in expanding its production platform into cell culture processes. Adimmune aims to leverage production efficiency through collaboration with Sartorius. This collaboration includes training programs on cell culture and process #purification trends and innovations, paving the way for Adimmune's #commercialization endeavors.

Stay tuned with #Globalbio for more insights into the latest trends and innovations in #biotechnology!

Read more: https://lnkd.in/ey-euSjr

#cell #vaccines